The head of the U.N. peacekeeping mission in ethnically split Cyprus says Greek Cypriots and Turkish Cypriots have reached an “understanding” over a contentious road inside a U.N.-controlled buffer zone whose construction had stirred up tensions not seen in years
The head of the U.N. peacekeeping mission in ethnically split Cyprus said Monday that Greek Cypriots and Turkish Cypriots have reached an “understanding” over a contentious road inside a U.N.-controlled buffer zone whose construction had stirred up tensions not seen in years. U.N. envoy Colin Stewart said a “few modalities” were still being discussed, although the framework of the deal would take effect right away.
will man a checkpoint along the newly built road to ensure that only Turkish Cypriots and European Union nationals can gain entry into the south, although Greek Cypriots won't be able to cross northward from there. The Cypriot government officials said that equally significant is that the entire area, which has been vacant for 49 years, is now designated for development — construction of homes, shops and businesses operating under EU law — for the benefit of both communities.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
One of 2022's Best Xbox Series X Games Reduced by $45This GameStop deal is the best Xbox Series X deal on the Internet right now.
Read more »
Dolphins' 'real-deal speed' was too much for Giants defenseThe Giants allowed 501 yards in the first three quarters. Tyreek Hill averaged 22.6 yards per catch and De’Von Achane averaged 13.7 per carry.
Read more »
Workers at Mack Trucks reject tentative contract deal and will go on strike early MondayThe UAW represents about 4,000 Mack workers in three states.
Read more »
Bristol Myers Squibb to buy Mirati Therapeutics in deal worth up to $5.8 billionMirati develops commercial-stage oncology therapies, and through the deal, Bristol Myers Squibb will add lung-cancer medicine Krazati, among others, to its...
Read more »
Bristol-Myers Squibb to acquire Mirati in $5.8 billion dealBristol-Myers Squibb (BMY.N) on Sunday said it will acquire Mirati Therapeutics (MRTX.O) in a transaction that values the cancer drugmaker at up to $5.8 billion.
Read more »